Medicare AdvantagePrior AuthMedium impact
Emrosi™ (minocycline) (New)
Humana·Dermatology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jul 23, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage plans now require prior authorization for Emrosi (minocycline extended-release capsules) used to treat rosacea. Patients must have tried and failed topical metronidazole and standard oral doxycycline before approval.
Action Required
By July 23, 2025: Clinical staff must obtain prior authorization from Humana Medicare Advantage before prescribing Emrosi for rosacea patients. Document previous treatment failures with topical metronidazole and non-delayed release oral doxycycline. Visit www.humana.com/PAL for prior authorization requirements. Claims will be denied without proper authorization.